OncoTherapy Science,Inc. [4564.T]
TOKYO, May 01 (Pulse News Wire) – Oncotherapy Science,inc. (4564.T) reported the exercise status of its 38th tranche subscription warrants (with adjustment clause) for April.
A total of 15,000,000 shares were delivered during the month, representing 18.84% of the total issuance. In April, 150,000 warrants were exercised. As of the end of March, there were 396,000 unexercised warrants outstanding, which decreased to 246,000 by the end of April. Key exercise details included: - April 10: 50,000 warrants exercised at ¥22.40 per share.
- April 16: 100,000 warrants exercised at ¥21.40 per share. At the end of April, the number of unexercised warrants stood at __NUM_6__ out of a total issuance of __NUM_5__. The company adhered to the exercise limits stipulated by the listing regulations, maintaining an exercise ratio of 4.43%. The total number of issued shares as of the end of March was 383,643,700 (including treasury shares of 128).
🟢 Confidence: High AI-translated content.